Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Neurofibroma, Plexiform × pirfenidone × Clear all

Phase

Phase 2 2 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1 CNS 1

Conditions

Precancerous Conditions 1 Pneumonia 1 Neurofibromatosis 1 1 Neurofibroma, Plexiform 1 Neoplasms 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

AZD 6244 2 pirfenidone 1 cabozantinib 1 Sorafenib 1 Pharmacokinetics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00053937 2015-04-30

Pirfenidone in Treating Young Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas

National Cancer Institute (NCI)

Phase 1 Completed

CNSOther neoplasm

Neurofibromatosis 1, Precancerous Conditions, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon ⚡